Myomo CMO Harry Kovelman sells $20,136 in company stock

FDA approves Enspryng for thyroid eye disease treatment

Investing.com · News 18m ago

Karur Vysya Bank shares jump 6% to hit a 52-week high after Q2 results - Should you buy? Rationale, target price

LiveMint · Markets 20m ago

Nidec says considering legal action against executives over accounting scandal

Investing.com · Investing_news 21m ago

Nidec says considering legal action against executives over accounting scandal

Investing.com · News 21m ago

Persistent Systems share price tumbles 5% after Q2 results 2026 | What should investors do? Check target price, rating

LiveMint · Markets 21m ago

Japan’s Fukoku Mutual Life Counts on Cash to Mitigate Volatility

Bloomberg · Markets 22m ago

Michael Palin on the Philippines and China’s Power

Bloomberg · Markets Video 22m ago

The IPO drought is driving private equity-owned companies to the debt market to pay investors

CNBC · Markets 22m ago

Metals Rebound as Sentiment Improves After US Inflation Shock

Bloomberg · Markets 24m ago

IMF Quite Confident Argentina Able to Meet 2027 Debt Obligations

Bloomberg · Markets 25m ago